[HTML][HTML] Phase I trial of daily oral Polyphenon E in patients with asymptomatic Rai stage 0 to II chronic lymphocytic leukemia
TD Shanafelt, TG Call, CS Zent, B LaPlant… - Journal of Clinical …, 2009 - ncbi.nlm.nih.gov
Journal of Clinical Oncology, 2009•ncbi.nlm.nih.gov
Phase I Trial of Daily Oral Polyphenon E in Patients With Asymptomatic Rai Stage 0 to II Chronic
Lymphocytic Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2727287
Other Formats PDF (115K) Actions Cite Collections Share Permalink Copy RESOURCES
Similar articles Cited by other articles Links to NCBI Databases Journal List J Clin Oncol …
Lymphocytic Leukemia - PMC Back to Top Skip to main content NIH NLM Logo Access keys
NCBI Homepage MyNCBI Homepage Main Content Main Navigation Search PMC Full-Text
Archive Search in PMC Advanced Search User Guide Journal List J Clin Oncol PMC2727287
Other Formats PDF (115K) Actions Cite Collections Share Permalink Copy RESOURCES
Similar articles Cited by other articles Links to NCBI Databases Journal List J Clin Oncol …
Abstract
Purpose
To define the optimal dose of Polyphenon E for chronic daily administration and tolerability in patients with chronic lymphocytic leukemia (CLL).
ncbi.nlm.nih.gov